Drug intelligence / Profile preview

Dog Allergen Extract

Development stage: Unknown
Lead developer: Jubilant HollisterStier
Modality: Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration: Subcutaneous, Percutaneous

Overview

Dog allergen extract is used for the diagnosis and treatment of allergies to dog dander and hair. It is administered through subcutaneous injection for immunotherapy and percutaneous use for diagnosis. The extract contains proteins such as Can f 1, which is crucial for effective diagnosis and treatment.

Brand names: AP Dog
Other names: Dog Hair and Dander Extract

Beyond the preview

Go deeper on Dog Allergen Extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dog Allergen Extract.

Explore the full profile